Data thru May 13, 2026
HomeTrendsArticlesDrug MarketsTherapeutic ClassesManufacturersPricingContact
Back to Market Feed

LOREEV XR 1.5 MG CAPSULE

lorazepam
$14.2367per EA
High Outlier
DEA Schedule CIV

Strength

1.5 mg/1

Manufacturer

Almatica Pharma LLC

NDC

52427066130

Classification

Brand

Dosage Form

CAPSULE, EXTENDED RELEASE

Route

ORAL

Last Updated

4/22/2026

Active Ingredients

LORAZEPAM

Approval Type

New Drug (NDA)

FDA Application

NDA214826

On Market Since

3/1/2022

Pharmacological Classes

Benzodiazepine
Benzodiazepines

Price History

1W

0.0%

1M

0.0%

3M

-0.1%

6M

-0.2%

1Y

-0.1%

3Y

N/A

5Y

N/A

All

+0.9%

Generic Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.

Related Drugs

Same classification

KLONOPIN 0.5 MG TABLET
Brand
61269060510•H2-Pharma LLC
$2.6797
per EA
KLONOPIN 1 MG TABLET
Brand
61269061010•H2-Pharma LLC
$3.0637
per EA
KLONOPIN 2 MG TABLET
Brand
61269062010•H2-Pharma LLC
$4.2603
per EA
HALCION 0.25 MG TABLET
Brand
00009001755•Pharmacia & Upjohn Company LLC
$5.3212
per EA
HALCION 0.25 MG TABLET
Brand
00009001758•Pharmacia & Upjohn Company LLC
$5.3212
per EA
XANAX 0.25 MG TABLET
Brand
00009002901•Pharmacia & Upjohn Company LLC
$5.6478
per EA
XANAX 0.25 MG TABLET
Brand
00009002902•Pharmacia & Upjohn Company LLC
$5.6478
per EA
XANAX 0.25 MG TABLET
Brand
58151045201•Viatris Specialty LLC
$5.6478
per EA
XANAX 0.25 MG TABLET
Brand
58151045205•Viatris Specialty LLC
$5.6478
per EA
XANAX 0.5 MG TABLET
Brand
00009005501•Pharmacia & Upjohn Company LLC
$7.0354
per EA

Data Source

Pricing data sourced from the National Average Drug Acquisition Cost (NADAC) survey, published by the Centers for Medicare & Medicaid Services (CMS). Updated weekly.

Disclaimer

This site is for informational purposes only and does not constitute medical, pharmaceutical, or financial advice. NADAC prices are survey-based estimates and may not reflect actual acquisition costs at any specific pharmacy.

Navigate

HomeAboutManufacturersDrug MarketsTherapeutic ClassesTrendsArticlesPricingContact

© 2026 NADAC Intelligence. All rights reserved. Not affiliated with CMS or any government agency.

Terms of ServicePrivacy Policy